Biodegradable microfibers deliver the antitumor drug temozolomide to glioma C6 cells in vitro

Pharmazie

Volumn 65, Issue 11, 2010, Pages 830-834

  Fan, Xiaoyong ^a   Ni, Shilei ^a   Qi, Hongxu ^b   Wang, Xuping ^a   Wang, Chuanwei ^a   Liu, Yuguang ^a  

^a SHANDONG UNIVERSITY   (China)

^b TSINGHUA UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINATE POLYLYSINE ALGINATE; CARBONIC ACID; NANOFIBER; POLYPROPYLENE; TEMOZOLOMIDE;

ARTICLE; BIODEGRADABILITY; CONTROLLED STUDY; CYTOTOXICITY; DIFFERENTIAL SCANNING CALORIMETRY; DRUG DELIVERY SYSTEM; ELECTROSPINNING; GLIOMA CELL; IN VITRO STUDY; MICROMORPHOLOGY; NANOFABRICATION; NEUROTOXICITY; SCANNING ELECTRON MICROSCOPY;

ANTINEOPLASTIC AGENTS, ALKYLATING; CALORIMETRY, DIFFERENTIAL SCANNING; CELL LINE, TUMOR; CELL SURVIVAL; DACARBAZINE; DRUG DELIVERY SYSTEMS; EXCIPIENTS; GLIOMA; HUMANS; MICROSCOPY, ELECTRON, SCANNING; PARTICLE SIZE; POLYPROPYLENES; TETRAZOLIUM SALTS; THIAZOLES;

EID: 78649575434     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2010.0156     Document Type: Article

References (31)

1. Abraham P, KI, KD (2005) Nitro-arginine methyl ester, a non-selective inhibitor of nitric oxide synthase reduces ibuprofen-induced gastric mucosal injury in the rat. Dig Dis Sci 50: 1632-1640.
2. Agrawal CM, Athanasiu KA (1997) Technique to control pH in vicinity of biodegrading PLA-PGA implants. J Biomed Mater Res 38: 105-114.
3. Akbar U, Jones T, Winestone J, Michael, M, Shukla A, Sun Y, Duntsch C (2009) Delivery of temozolomide to the tumor bed via biodegradable gel matrices in a novel model of intracranial glioma with resection. J Neurooncol 94: 203-212.
4. Attenello, FJ, Mukherjee D, Datoo G, Mcgirt, MJ, Bohan E, Weingart JD, Olivi A, Quinones-Hinojosa A, Brem H (2008) Use of Gliadel (BCNU) wafer in the surgical treatment of malignant glioma: A 10-year institutional experience. Ann Surg Oncol 15: 2887-2893.
5. Azizi SA, Miyamoto C (1998) Principles of treatment of malignant gliomas in adults: an overview. J Neurovirol 4: 204-216.
6. Brem S, Tyler B, Li K, Pradilla G, Legnani F, Caplan J, Brem H (2007) Local delivery of temozolomide by biodegradable polymers is superior to oral administration in a rodent glioma model. Cancer Chemother Pharmacol 60: 643-650.
7. Drappatz J, Norden AD, Wong ET, Doherty LM, Lafrankie DC, Ciampa A, Kesari S, Sceppa C, Gerard M, Phan P, Schiff D, Batchelor TT, Ligon KL, Young G, Muzikansky A, Weiss SE, Wen PY (2010) Phase I study of vandetanib with radiotherapy and temozolomide for newly diagnosed glioblastoma. Int J Radiat Oncol Biol Phys, in press.
8. Du LC, Meng YZ, Wang SJ, Tjong SC (2004) Synthesis and degradation behavior of poly(propylene carbonate) derived from carbon dioxide and propylene oxide. J Appl Polym Sci 92: 1840-1846.
9. Elkharraz K, Faisant N, Guse C, Siepmann F, Arica-Yegin B, Oger JM, Gust R, Goepferich A, Benoit JP, Siepmann J (2006) Paclitaxel-loaded microparticles and implants for the treatment of brain cancer: preparation and physicochemical characterization. Int J Pharm 314: 127-136.
10. Fine, HA, Dear, KB, Loeffler JS, Black PM, Canellos GP (1993) Metaanalysis of radiation therapy with and without adjuvant chemotherapy for malignant gliomas in adults. Cancer 71: 2585-2597.
11. Galldiks N, Kracht LW, Burghaus L, Ullrich RT, Backes H, Brunn A, Heiss WD, Jacobs AH (2010) Patient-tailored, imaging-guided, long-term temozolomide chemotherapy in patients with glioblastoma. Mol Imaging 9: 40-46.
12. Gallia GL, Brem S, Brem H (2005) Local treatment of malignant brain tumors using implantable chemotherapeutic polymers. J Natl Compr Canc Netw 3: 721-728.
13. Garside R, Pitt M, Anderson R, Rogers G, Dyer M, Mealing S, Somerville M, Price A, Stein K (2007) The effectiveness and cost-effectiveness of carmustine implants and temozolomide for the treatment of newly diagnosed high-grade glioma: a systematic review and economic evaluation. Health Technol Assess, 11, iii-iv, ix-221.
14. Gururamgan S, Cokgor L, Rich JN, Edwards S, Affronti ML, Quinn JA, Herndon JE 2nd, Provenzale JM, Mclendon, RE, Tourt-Uhlig S, Sampson JH, Stafford-Fox V, Zaknoen S, Early M, Friedman AH, Friedmann HS (2001) Phase I study of Gliadel wafers plus temozolomide in adults with recurrent supratentorial high-grade gliomas. Neuro Oncol 3: 246-250.
15. Jemal A, Siegel R, Ward E, Murray T, Xu J, Thun MJ (2007) Cancer statistics 2007. CA Cancer J Clin 57: 43-66.
16. Kong DS, Lee JI, Kim JH, Kim, ST, Kim WS, Suh YL, Dong SM, Nam DH (2010) Phase II trial of low-dose continuous (metronomic) treatment of temozolomide for recurrent glioblastoma. Neuro Oncol 12: 289-296.
17. Kumar Naraharisetti P, Yung Sheng Ong B, Wei Xie J, Kam Yiu Lee T, Wang CH, Sahinidis NV (2007) In vivo performance of implantable biodegradable preparations delivering paclitaxel and etanidazole for the treatment of glioma. Biomaterials 28: 886-894.
18. Lin R, Shi Ng L, Wang, CH (2005) In vitro study of anticancer drug doxorubicin in PLGA-based microparticles. Biomaterials 26: 4476-4485.
19. Pan E, Mitchell SB, Tsai JS (2008) A retrospective study of the safety of BCNU wafers with concurrent temozolomide and radiotherapy and adjuvant temozolomide for newly diagnosed glioblastoma patients. J Neurooncol 88: 353-357.
20. Peereboom DM, Shepard DR, Ahluwalia MS, Brewer CJ, Agarwal N, Stevens GH, Suh JH, Toms SA, Vogelbaum MA, Weil RJ, Elson P, Barnett GH (2010) Phase II trial of erlotinib with temozolomide and radiation in patients with newly diagnosed glioblastoma multiforme. J Neurooncol 98: 93-99.
21. Reni M, Mason W, Zaja F, Perry J, Franceschi E, Bernardi D, Dell'Oro S, Stelitano C, Candela M, Abbadessa A, Pace A, Bordonaro R, Latte G, Villa E, Ferreri AJ (2004) Salvage chemotherapy with temozolomide in primary CNS lymphomas: preliminary results of a phase II trial. Eur J Cancer 40: 1682-1688.
22. Smith LA, Ma PX (2004) Nano-fibrous scaffolds for tissue engineering. Colloids Surf B Biointerfaces 39: 125-131.
23. Sonabend AM, Velicu S, Ulasov IV, Han Y, Tyler B, Brem H, Matar MM, Fewell JG, Anwer K, Lesniak MS (2008) A safety and efficacy study of local delivery of interleukin-12 transgene by PPC polymer in a model of experimental glioma. Anticancer Drugs 19: 133-142.
24. Stewart LA (2002) Chemotherapy in adult high-grade glioma: a systematic review and meta-analysis of individual patient data from 12 randomised trials. Lancet 359: 1011-1018.
25. Tominaga H, Ishiama M, Oheseto F, Sasamoto K, Hamamoto T, Suzuki K, Watanabe M (1999) A water-soluble tetrazolium salt useful for colorimetric cell viability assay. Anal Commun 36: 47-50.
26. Trent S, Kong A, Short SC, Traish D, Ashley S, Dowe A, Hines F, Brada M (2002) Temozolomide as second-line chemotherapy for relapsed gliomas. J Neurooncol 57: 247-251.
27. Ushio Y, Hayakawa T, Hasegawa H, Yamada K, Arita N (1984) Chemotherapy of malignant gliomas. Neurosurg Rev 7: 3-12.
28. Wang, PP, Frazier J, Brem H (2002) Local drug delivery to the brain. Adv Drug Deliv Rev 54: 987-1013.
29. Westphal, M, Hilt DC, Bortey E, Delavault P, Olivares R, Warnke PC, Whittle IR, Jaaskelainen J, Ram Z (2003) A phase 3 trial of local chemotherapy with biodegradable carmustine (BCNU) wafers (Gliadel wafers) in patients with primary malignant glioma. Neuro Oncol 5: 79-88.
30. Xie J, Wang, CH (2005) Self-assembled biodegradable nanoparticles developed by direct dialysis for the delivery of paclitaxel. Pharm Res 22: 2079-2090.
31. Zhang H, Gao S (2007) Temozolomide/PLGA microparticles and antitumor activity against glioma C6 cancer cells in vitro. Int J Pharm 329: 122-128.